Benzodiazepine addiction treatment on Long Island may involve medical evaluation, withdrawal management, mental health care and continuing support tailored to the individual. Benzodiazepines — including Xanax, Klonopin, Ativan and Valium — can be medically appropriate when prescribed for certain anxiety disorders, seizures, insomnia or other conditions. However, repeated use may also lead to physical dependence, misuse or a benzodiazepine use disorder.
People who have taken benzodiazepines regularly should not stop suddenly without medical guidance. Abrupt discontinuation or reducing the dose too quickly can produce serious withdrawal reactions, including seizures. The U.S. Food and Drug Administration recommends an individualized, gradual reduction under clinical supervision rather than a one-size-fits-all discontinuation schedule.
For confidential help understanding treatment options on Long Island, contact the Long Island Rehab Treatment Helpline. A trained representative can discuss your situation, explain appropriate levels of care and help identify possible next steps.
What are benzodiazepines?
Benzodiazepines are prescription medications that reduce activity in the central nervous system. They enhance the effects of gamma-aminobutyric acid, commonly called GABA, which produces calming, sedating and anticonvulsant effects.
Common benzodiazepines include:
- Alprazolam: Xanax
- Clonazepam: Klonopin
- Lorazepam: Ativan
- Diazepam: Valium
- Temazepam: Restoril
- Triazolam: Halcion
- Chlordiazepoxide: Librium
These medications differ in how quickly they begin working, how long their effects last and the conditions for which they may be prescribed. Nevertheless, all benzodiazepines carry clinically important risks involving misuse, physical dependence and withdrawal.
The FDA requires benzodiazepines to carry its most prominent warning regarding abuse, misuse, addiction, physical dependence and withdrawal reactions. These risks may occur even when the medication was originally prescribed for a legitimate medical condition.
Half-life ranges are approximate and can vary with age, metabolism, active metabolites and concurrent medications. Source: FDA prescribing information.
| Medication (generic / brand) | Onset | Elimination half-life | Clinical notes |
|---|---|---|---|
| Alprazolam (Xanax) | Rapid (~15–30 min) | ~11 hours | Short-acting; more intense inter-dose rebound and withdrawal. |
| Lorazepam (Ativan) | Intermediate (~30–60 min) | ~10–20 hours | No active metabolites; often used in medical settings. |
| Clonazepam (Klonopin) | Intermediate | ~30–40 hours | Long-acting; steadier blood levels but prolonged taper timelines. |
| Diazepam (Valium) | Rapid | ~20–70 hours (active metabolites can persist for days) | Long-acting; sometimes used as a cross-taper agent under clinical direction. |
| Temazepam (Restoril) | Slow (~45–60 min) | ~8–15 hours | Primarily prescribed for insomnia. |
| Triazolam (Halcion) | Rapid | ~2–5 hours | Very short-acting; higher risk of rebound insomnia. |
| Chlordiazepoxide (Librium) | Slow | ~24–100+ hours (with active metabolites) | Long-acting; historically used in alcohol withdrawal protocols. |
Half-life ranges are approximate and vary with age, metabolism, active metabolites and concurrent medications. Data are drawn from FDA prescribing information and standard clinical references. For a full clinical comparison of alprazolam and clonazepam, see the ISSUP knowledge share on clonazepam vs. alprazolam.
Benzodiazepine dependence versus addiction
Physical dependence and addiction are related but distinct conditions.
Physical dependence
Physical dependence means the body has adapted to the continued presence of a medication. When the dosage is substantially reduced or discontinued, withdrawal symptoms can occur.
A person can become physically dependent while taking a benzodiazepine exactly as prescribed. Dependence alone does not necessarily mean the person has an addiction.
Benzodiazepine addiction
Addiction — or benzodiazepine use disorder — involves a problematic pattern of use that may include:
- Taking more than prescribed
- Using the medication more frequently than directed
- Being unable to reduce or control use
- Obtaining pills from multiple sources
- Using another person’s prescription
- Continuing despite medical, occupational or relationship consequences
- Combining benzodiazepines with alcohol, opioids or other substances
- Spending significant time obtaining, using or recovering from the medication
- Experiencing persistent cravings
- Using the medication for intoxication rather than its prescribed purpose
A person may have physical dependence without addiction, addiction with physical dependence, or both. A clinical assessment is needed to distinguish among prescribed use, dependence, misuse and a substance use disorder.
A clinical assessment is needed to distinguish prescribed use, dependence, misuse and a use disorder.
Signs that benzodiazepine use may be becoming dangerous
Warning signs can differ depending on the medication, dosage, duration of use and whether other substances are involved.
Possible signs include:
- Increasing the dose without medical approval
- Running out of prescriptions early
- Taking benzodiazepines to manage ordinary stress or emotions
- Memory problems or periods of lost time
- Excessive sedation
- Poor coordination
- Slurred speech
- Falls or accidents
- Difficulty concentrating
- Reduced performance at work or school
- Withdrawing from family and normal activities
- Feeling unable to function without the medication
- Experiencing withdrawal symptoms between doses
- Mixing benzodiazepines with alcohol, opioids or sleep medications
Someone does not need to display every sign to benefit from an evaluation.
Can benzodiazepine withdrawal be dangerous?
Yes. Benzodiazepine withdrawal can become medically serious and, in some circumstances, life-threatening.
Possible withdrawal symptoms include:
- Increased anxiety
- Panic attacks
- Insomnia
- Irritability
- Restlessness
- Tremors
- Sweating
- Muscle pain or stiffness
- Nausea
- Sensitivity to light or sound
- Difficulty concentrating
- Changes in perception
- Depression
- Confusion
- Hallucinations
- Seizures
The FDA warns that abruptly stopping benzodiazepines or reducing the dosage too quickly can cause acute withdrawal reactions, including potentially life-threatening seizures.
The risk and intensity of withdrawal can be affected by:
- The benzodiazepine being taken
- Whether it is short-acting or long-acting
- The daily dosage
- How long it has been used
- Previous withdrawal episodes
- Co-occurring medical or psychiatric conditions
- Concurrent alcohol, opioid or other drug use
- Individual differences in metabolism and response
Because these variables matter, no universal tapering schedule is appropriate for everyone.
For a phase-by-phase walk-through of what patients typically experience, see our clinician-reviewed benzodiazepine withdrawal timeline.
The acute phase carries the highest risk of seizures and other severe complications. Onset and duration vary with dose, medication half-life and duration of use.
Should someone stop taking Xanax, Klonopin or Ativan immediately?
Not without medical direction.
A person who has been taking a benzodiazepine regularly should speak with the prescribing clinician or another qualified medical professional before changing the dose. The 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering emphasizes gradual, patient-centered dose reduction when the risks of continued use outweigh the benefits. The pace should be adjusted based on the individual’s response rather than imposed as a rigid schedule.
LongIsland.rehab does not provide individualized tapering instructions online. A taper is a medical intervention and should be designed around the person’s prescription history, health status, symptoms and concurrent substance use.
Educational illustration only. The 2025 Joint Clinical Practice Guideline recommends individualized, patient-centered pacing rather than a fixed schedule.
Why mixing benzodiazepines with opioids or alcohol is especially dangerous
Benzodiazepines, opioids and alcohol can all suppress central nervous system activity.
When combined, their effects may intensify and lead to:
- Profound sedation
- Impaired judgment
- Loss of coordination
- Blackouts
- Slowed or stopped breathing
- Coma
- Fatal overdose
The FDA specifically warns that combining benzodiazepines with opioids, alcohol or other central nervous system depressants increases the risk of severe respiratory depression and death.
A person using benzodiazepines together with opioids or alcohol should disclose all substance use during assessment. This information affects withdrawal planning, medical monitoring and the appropriate level of care.
The FDA warns that combining benzodiazepines with opioids, alcohol or other CNS depressants can cause severe respiratory depression and death.
What does benzodiazepine addiction treatment involve?
Treatment should be based on a comprehensive assessment rather than the name of the medication alone.
A benzodiazepine treatment plan may include the following components.
Placement is determined by clinical assessment, not medication name alone. New York State OASAS certifies programs at each level of care in Nassau and Suffolk counties.
Medical and psychiatric assessment
An initial assessment may examine:
- Current prescriptions and dosages
- Duration and pattern of benzodiazepine use
- Alcohol, opioid and other substance use
- Past withdrawal symptoms or seizures
- Anxiety, depression, trauma or sleep disorders
- Physical health conditions
- Prior treatment episodes
- Current medications
- Family and social support
- Safety concerns, including suicidal thoughts
This evaluation helps determine whether the individual requires emergency care, hospital-level treatment, supervised withdrawal management or a less intensive setting.
Medically supervised withdrawal management
Some people require structured medical monitoring while reducing or discontinuing benzodiazepines.
Withdrawal management may involve:
- Monitoring vital signs and symptoms
- Preventing or responding to complications
- Reviewing other medications and substances
- Adjusting the taper when symptoms become difficult
- Stabilizing co-occurring medical or psychiatric conditions
- Planning the transition into continuing treatment
Withdrawal management alone is not the same as complete addiction treatment. It addresses immediate physiological stabilization, while ongoing care addresses the behaviors, mental health conditions and circumstances associated with continued use.
Residential treatment
Residential treatment provides a structured living environment with continuous support.
It may be considered when someone has:
- Repeated unsuccessful attempts to stop
- Significant polysubstance use
- Unstable living conditions
- Severe psychiatric symptoms
- High relapse risk
- Limited support at home
- Difficulty remaining safe in an outpatient setting
The appropriate placement should be based on clinical need.
Partial hospitalization and intensive outpatient treatment
Partial hospitalization programs and intensive outpatient programs offer structured treatment while allowing participants to live outside the facility.
Services may include:
- Individual therapy
- Group counseling
- Psychiatric care
- Medication management
- Relapse-prevention planning
- Family education
- Case management
- Monitoring for continued substance use
These programs are not appropriate substitutes for hospital or medically managed care when acute withdrawal risks are present.
Standard outpatient treatment
Traditional outpatient care may be appropriate for people who are medically stable and have sufficient support.
It may involve scheduled therapy, psychiatric appointments, medication management and recovery support.
Continuing care
Recovery does not end when a taper or formal program is completed.
Continuing care may include:
- Ongoing behavioral health treatment
- Peer-support meetings
- Medication monitoring
- Relapse-prevention planning
- Family involvement
- Recovery coaching
- Treatment for anxiety, insomnia or trauma via dual-diagnosis care, coordinated with mental-health providers
- Coordination with primary care and psychiatry
The goal is not simply to discontinue a medication. It is to help the person function safely without returning to harmful use.
Treating anxiety without reinforcing benzodiazepine misuse
Many people began taking benzodiazepines because they were experiencing real anxiety, panic attacks, insomnia or trauma symptoms.
Those underlying concerns should not be dismissed when benzodiazepine risks emerge.
Treatment may include:
- Cognitive behavioral therapy
- Exposure-based therapy when clinically appropriate
- Trauma-informed treatment
- Sleep-focused behavioral interventions
- Non-benzodiazepine medications when prescribed
- Stress-management skills
- Treatment for depression or other co-occurring disorders
- Family or relationship counseling
Medication decisions should be made by a qualified prescriber. The objective is to address the original condition while reducing the risks associated with continued benzodiazepine use.
How long does benzodiazepine treatment take?
There is no universal timeline.
The length of treatment may depend on:
- The medication and dosage
- Duration of use
- Severity of dependence
- Presence of addiction
- Co-occurring alcohol or opioid use
- Psychiatric symptoms
- Previous withdrawal experiences
- Stability at home
- Progress during treatment
- Insurance coverage and available resources
Some people require a prolonged, carefully monitored taper. Others may need residential or intensive behavioral treatment in addition to medical management. Attempting to accelerate the process solely to meet a predetermined deadline can increase distress and medical risk.
Does insurance cover benzodiazepine addiction treatment on Long Island?
Insurance coverage varies by:
- Health plan
- Medical necessity
- Level of care
- Provider network
- Deductible
- Copayment or coinsurance
- Prior authorization requirements
- Length-of-stay approval
Before entering treatment, ask for verification of benefits and a clear explanation of potential out-of-pocket costs.
Useful questions include:
- Is the program in network?
- Is withdrawal management covered?
- Is residential treatment covered?
- Does the plan require prior authorization?
- What deductible remains?
- What is the expected daily or program copayment?
- Are psychiatric and medication-management services included?
- What happens if continued treatment is denied?
Do not assume that “insurance accepted” means treatment will be fully covered.
Finding benzodiazepine treatment on Long Island
The right program should be able to explain:
- What conditions it treats
- Whether it provides medical withdrawal management
- Which levels of care are available
- How psychiatric care is incorporated
- How emergencies are handled
- Whether it treats co-occurring substance use
- How families are involved
- What happens after discharge
- Which insurance plans are accepted
- Whether the facility is licensed or accredited for the services advertised
Avoid any organization that promises an instant cure, provides a rigid taper without assessment or encourages a person to discontinue benzodiazepines abruptly.
When should a family seek help?
Consider requesting an assessment when someone:
- Cannot reduce use without becoming ill
- Takes medication differently from the prescription
- Combines benzodiazepines with alcohol or opioids
- Experiences repeated blackouts
- Has had an overdose
- Has become increasingly sedated or confused
- Is obtaining medication from multiple sources
- Continues using despite serious consequences
- Has worsening depression or suicidal thoughts
- Has experienced withdrawal seizures
- Cannot maintain work, school or family responsibilities
Families do not need to wait for the situation to become catastrophic.
Related benzodiazepine resources
For more detail on specific medications and treatment settings, see our benzodiazepine addiction overview, Xanax addiction, Ativan addiction, Valium addiction, and medical detox.
Frequently Asked Questions
What is the safest way to stop taking benzodiazepines?
People who have taken benzodiazepines regularly should consult a qualified medical professional before reducing or discontinuing them. Abrupt discontinuation can cause severe withdrawal reactions, including seizures. A gradual and individualized taper is generally recommended when discontinuation is appropriate.
Can someone become dependent on benzodiazepines when taking them as prescribed?
Yes. Physical dependence can occur during prescribed use. Dependence does not automatically mean addiction, but it can produce withdrawal symptoms when the medication is reduced or stopped.
Is Xanax withdrawal more dangerous than Klonopin withdrawal?
Both can produce serious withdrawal. Differences in onset and duration may affect how symptoms appear, but individual dosage, duration of use, health history and other substance use are also important. A clinician should evaluate the person rather than assuming safety based solely on the medication name.
Is benzodiazepine detox enough to treat addiction?
Usually not. Withdrawal management addresses immediate physical stabilization. Addiction treatment may also require therapy, psychiatric care, relapse prevention, family support and continuing care.
Can benzodiazepines be mixed with alcohol?
They should not be combined unless a qualified clinician has explicitly addressed the situation. Alcohol can intensify sedation and respiratory suppression, increasing the risk of overdose, coma and death.
Does everyone with benzodiazepine dependence need residential treatment?
No. Placement depends on withdrawal risk, psychiatric stability, polysubstance use, home support and other clinical factors. Some people may be treated in outpatient settings, while others require supervised or residential care.